Form 8-K · Current report
TJX Companies 8-K, filed Oct 20, 2026
- Filed
- CIK
- 0000109198
- Accession no.
- 0000109198-26-000054
Summary
TJX Companies entered into a letter agreement with Kenneth Canestrari, its Senior Executive Vice President and Group President, extending his employment through his planned retirement on April 30, 2027, with him ceasing to serve as an executive officer effective January 31, 2027.
Key points
- The agreement amends Canestrari's employment agreement dated February 2, 2018, most recently amended as of February 2, 2024.
- From January 31, 2027 until his retirement, Canestrari will continue as Senior Executive Vice President, performing transition duties specified by the company.
- He will not participate in the Management Incentive Plan or Long Range Performance Incentive Plan for performance periods beginning in fiscal year 2028 or later, and will receive no new equity grants under the Stock Incentive Plan.
- He remains subject to continuing non-competition, non-solicitation and confidentiality obligations.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
From the filing
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 15, 2026, The TJX Companies, Inc. (the “Company”) entered into a letter agreement (the “Agreement”) with Kenneth Canestrari, Senior Executive Vice President, Group President, in connection with his planned retirement from the Company. The Agreement amends Mr. Canestrari’s employment agreement with the Company dated February 2, 2018, as most recently amended as of February 2, 2024 (the “Employment Agreement”). Under the Agreement, Mr. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.